1280335

Hubei Haosun Pharmaceutical Co., Ltd. — FEI 3005178749

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 1, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ezhou (China)